tailieunhanh - Báo cáo khoa học: Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2

The human ATP-binding cassette (ABC) transporter, ABCG2 (BCRP⁄ MXR⁄ABCP), is a plasma membrane protein containing intramolecular and intermolecular disulfide bonds and anN-linked glycan at Asn596. We have recently reported that the intramolecular disulfide bond is a critical checkpoint for determining the degradation fates of ABCG2. | ỊFEBS Journal Disruption of N-linked glycosylation enhances ubiquitin-mediated proteasomal degradation of the human ATP-binding cassette transporter ABCG2 Hiroshi Nakagawa Kanako Wakabayashi-Nakao Ai Tamura Yu Toyoda Shoko Koshiba and Toshihisa Ishikawa Department of Biomolecular Engineering Graduate Schoolof Bioscience and Biotechnology Tokyo Institute of Technology Midori-ku Yokohama Japan Keywords ABC transporter ABCG2 N-linked glycosylation proteasome ubiquitin Correspondence Toshihisa Ishikawa Omics Science Center RIKEN Yokohama Institute 1-7-22 Suehiro-cho Tsurumi-ku Yokohama 230-0045 Japan Fax 81 45 503 9216 Tel 81 45 503 9222 or 9179 E-mail toshi-i@ Received 2 May 2009 revised 7 September 2009 accepted 5 October 2009 doi The human ATP-binding cassette ABC transporter ABCG2 BCRP MXR ABCP is a plasma membrane protein containing intramolecular and intermolecular disulfide bonds and an N-linked glycan at Asn596. We have recently reported that the intramolecular disulfide bond is a critical checkpoint for determining the degradation fates of ABCG2. In the present study we aimed to analyze quantitatively the impact of the N-linked glycan on the protein stability of ABCG2. For this purpose we incorporated one single copy of ABCG2 cDNA into a designated site of genomic DNA in Flp-In-293 cells to stably express ABCG2 or its variant proteins. When ABCG2 wild type-expressing cells were incubated with various N-linked glycosylation inhibitors tunicamycin profoundly suppressed the protein expression level of ABCG2 and accordingly reduced the ABCG2-mediated cellular resistance to the cancer chemotherapeutic SN-38. When Asn596 was converted to Gln596 the resulting variant protein was not glycosylated and its protein level was about one-third of the wild type level in Flp-In-293 cells. Treatment with MG132 a proteasome inhibitor increased the level of the variant protein. Immunoblotting with anti-ubiquitin IgG1k after .

crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.